Day 039 - 20 Oct 94 - Page 37
1 not finish Dr. Millstone tomorrow. I am sure we shall.
2
3 MR. JUSTICE BELL: What I would like you to do, Mr. Morris and
4 Ms. Steel, if you are going to ask questions as well, is
5 direct yourselves to completing Dr. Millstone's evidence
6 this afternoon. If, at the end of the afternoon, there are
7 important matters which you think you have not covered tell
8 me. It seems to me more reasonable to be able to do that.
9 If you can do it before the end of the afternoon well and
10 good. It is very important, in my view, that you come back
11 tomorrow to complete your evidence in one go, but we are
12 very hopeful that that will be the end of your evidence
13 tomorrow, Dr. Millstone.
14
15 (Short Adjournment)
16 2.00 p.m.
17
18 MR. MORRIS: Yes. We will try and whack on here. Dr. Millstone
19 said he would stay until a bit later if we can possibly get
20 it over today.
21
22 MR. JUSTICE BELL: Yes, we will sit a little bit later, if
23 necessary. The confines on sitting are staff
24 considerations, not ones personal to me.
25
26 MR. MORRIS (To the witness): On the references on BHA and BHT,
27 you wanted to refer to No. 54, Dr. Millstone. It was a
28 different one to the one we had before. Which particular
29 one was it? Was it the urticaria or the dermatitis?
30 A. Well, both of those, I think, provide some direct human
31 evidence that -----
32
33 Q. This is No. 54 of the references.
34 A. Yes, urticaria is a relatively specific type of
35 dermatitis. Dermatitis is a general inflammation of the
36 skin. Urticaria is a particular kind of dermatitis, and
37 both the study by Thune and Granholt in Dermitalogica 75.
38
39 Q. That is the first of the references?
40 A. That is the first of them, and the paper by Juhlin in
41 the British Journal of Dermitology in 1981 report on
42 dermatological effects that are in some cases ascribed to
43 BHA and BHT.
44
45 Q. Just before we look at the specific bits, the last one of
46 the 54 references in tab 54, is also Hannuksela. Is that
47 relevant as well?
48 A. Oh, the contact dermatitis paper by -----
49
50 Q. "It is the Peroral Challenge Tests with Food Additives in
51 Urticaria and Atopic Dermatitis"?
52 A. Yes.
53
54 Q. Do you want to just refer us to may be the most significant
55 of those three?
56 A. No, I deem them all to be equally significant.
57
58 Q. Do you want to refer us to the relevant abstract or
59 whatever?
60 A. OK. Let us briefly do that. I think these are
